Sentences with phrase «women with breast cancer say»

Not exact matches

As a woman, I can not say enough about how important it is that we all know about breast cancer, how to detect it, and steps to take to support those with breast cancer.

«For women with a family history of breast cancer, this suggests an extra benefit [of breastfeeding] is, it may reduce the risk of breast cancer,» says Alison Stuebe, MD, an assistant professor of obstetrics and gynecology at the University of North Carolina at Chapel Hill, the lead author of the study.

The American Cancer Society's guidelines say women ages 40 to 44 «should have the choice to start annual breast cancer screening with mammograms if they wish to do so»; women from 45 to 54 «should get mammograms every year»; and women 55 and older «should switch to mammograms every 2 years, or have the choice to continue yearly screening.&Cancer Society's guidelines say women ages 40 to 44 «should have the choice to start annual breast cancer screening with mammograms if they wish to do so»; women from 45 to 54 «should get mammograms every year»; and women 55 and older «should switch to mammograms every 2 years, or have the choice to continue yearly screening.&cancer screening with mammograms if they wish to do so»; women from 45 to 54 «should get mammograms every year»; and women 55 and older «should switch to mammograms every 2 years, or have the choice to continue yearly screening.»

Cuomo, who spoke of his girlfriend Sandra Lee's battle with breast cancer, said his legislation was the first of its kind in the United States, making both breast cancer screenings and follow - up tests free to women.

James said that while there is a 99 percent survival rate if breast cancer is detected early, black women are 42 percent more likely to die from breast cancer than their white counterparts and Hispanic women have significantly higher rates of being diagnosed with advanced breast cancer than either white or black women.

Commenting on research, to be published in the July issue of The Oncologist, looking at discrimination in treatment of older women with breast cancer, Jane Hatfield, Director of Policy and Research at Breast Cancer Care,breast cancer, Jane Hatfield, Director of Policy and Research at Breast Cancer Care,cancer, Jane Hatfield, Director of Policy and Research at Breast Cancer Care,Breast Cancer Care,Cancer Care, said:

Women with one of the mutations have a 45 percent to 85 percent chance of developing breast cancer by age 70, 23andMe said.

Li says he and colleagues at the Fred Hutchinson Cancer Research Center and the University of Washington found the correlation between migraines and breast cancer during a survey of 2,000 post-menopausal women with breast cancer and 1,500 post-menopausal women with no history of breast cCancer Research Center and the University of Washington found the correlation between migraines and breast cancer during a survey of 2,000 post-menopausal women with breast cancer and 1,500 post-menopausal women with no history of breast ccancer during a survey of 2,000 post-menopausal women with breast cancer and 1,500 post-menopausal women with no history of breast ccancer and 1,500 post-menopausal women with no history of breast cancercancer.

«These are women with advanced metastatic cancer whose disease was kept in check without the use of toxic and life - disrupting chemotherapy,» says Dr. Massimo Cristofanilli, M.D., Director of the Breast Care Center at Thomas Jefferson University and senior author of the study.

«Recent studies have reported supplemental cancer detection rates of 1.9 per 1,000 women screened with automated whole breast ultrasound and 1.2 to 2.8 per 1,000 women screened with digital breast tomosynthesis, so our finding of an additional 8.8 cancers per 1,000 women makes MBI a very compelling option for women who elect supplemental screening,» says Dr. Rhodes.

«The compelling results seen in this global study provide unequivocal evidence supporting the clinical utility of Oncotype DX to risk - stratify patients with early stage breast cancer, and indicate that the findings are generalizable to everyday clinical practice,» said lead author Joseph A. Sparano, MD, vice-chairman of medical oncology at Montefiore Einstein Center for Cancer Care, and professor of medicine and of obstetrics, gynecology, women's health at Albert Einstein College of Medcancer, and indicate that the findings are generalizable to everyday clinical practice,» said lead author Joseph A. Sparano, MD, vice-chairman of medical oncology at Montefiore Einstein Center for Cancer Care, and professor of medicine and of obstetrics, gynecology, women's health at Albert Einstein College of MedCancer Care, and professor of medicine and of obstetrics, gynecology, women's health at Albert Einstein College of Medicine.

«These findings will give women with early stage breast cancer greater certainty that anti-estrogen therapy will decrease their risk of recurrence and increase their chance for survival whereas chemotherapy will not,» said breast cancer survivor Mary Lou Smith, JD, MBA, who helped design the study as a leader in the ECOG - ACRIN Cancer Research Advocates Commcancer greater certainty that anti-estrogen therapy will decrease their risk of recurrence and increase their chance for survival whereas chemotherapy will not,» said breast cancer survivor Mary Lou Smith, JD, MBA, who helped design the study as a leader in the ECOG - ACRIN Cancer Research Advocates Commcancer survivor Mary Lou Smith, JD, MBA, who helped design the study as a leader in the ECOG - ACRIN Cancer Research Advocates CommCancer Research Advocates Committee.

«Our findings highlight the potential value for a randomized controlled trial of aspirin as an agent in early detection of breast cancer, particularly for women with naturally dense tissues who may be at an increased risk for certain cancers,» said Despina Kontos, PhD, assistant professor of Radiology, and co-author on the study.

If a woman with a strong family history of breast and ovarian cancers tests negative for the BRCA1 / 2 genes, that does not mean her relatives are not at risk, says Daly — her siblings could still carry the gene, or there could be additional genes present that predispose them to cancer that clinicians don't yet know how to test for.

If a woman has an abortion, she's left with a large number of these immature cells lining her breast ducts, and she is therefore more vulnerable to cancer down the road — 30 percent more vulnerable, Brind says, than a woman who has never had an abortion.

«If you are a young woman who was treated with radiation therapy to your chest as a teenager or child for HL, or for that matter chest radiation therapy for any reason, you should be having a conversation with your family doctor or your oncologist about whether to start breast cancer screening earlier than most women would,» says Dr. Hodgson.

«In the future, we'd like to be able to profile individual cancer genomes so that we can identify the treatment most likely to be successful for a woman or man diagnosed with breast cancer,» says Dr Nik - Zainal of the Sanger Institute.

said Judith K. Wolf, MD, Chief Medical Officer of Provista Diagnostics, Inc. «This study shows that, with an over 99 percent negative predictive value (NPV), clinicians can confidently use Videssa Breast to detect cancer in women with dense breasts and better determine when biopsy is truly warranted to assess suspicious findings.»

«We found an association between increased breast cancer recurrence in women with a primary breast cancer tumor that was positive for the IGF1 receptor, which is consistent with other studies,» said Emond.

«In addition to having a higher prevalence of triple - negative breast cancers than Caucasian women — something that has been documented in previous studies — we found that African American women with breast cancer had a significantly higher prevalence of the TP53 driver mutation, basal tumor subtype and greater genomic diversity within tumors, all of which suggest more aggressive tumor biology,» says Tanya Keenan, MD, of the MGH Cancer Center, lead author of the cancer had a significantly higher prevalence of the TP53 driver mutation, basal tumor subtype and greater genomic diversity within tumors, all of which suggest more aggressive tumor biology,» says Tanya Keenan, MD, of the MGH Cancer Center, lead author of the Cancer Center, lead author of the study.

Dr Tan, a breast cancer doctor, said, «Therapeutic options remain limited and women with TNBC have a higher risk of disease relapse, with prognosis being generally poor after a relapse.

«To evaluate these findings in a group with only one HER2 treatment, we are currently analyzing data from another clinical trial, the GeparQuinto clinical trial, which is a randomized, phase III clinical trial evaluating two different neoadjuvant therapy regimens with a single anti-HER2 treatment [trastuzumab or lapatinib] for women with HER2 - positive breast cancer,» said Loibl.

Given those findings, the researchers say, about 46 percent of women with breast cancer who are classified as high risk based on clinical factors might not need chemo.

«Our study offers the first evidence — seen in breast tissue — that high saturated fatty acids in the breast adipose tissue is associated with presence of breast cancer in postmenopausal women,» says senior author and investigator Sungheon G. Kim, PhD, associate professor in the Department of Radiology at NYU Langone and a researcher at the Center for Advanced Imaging, Innovation, and Research.

«Our major goal is to test this hypothesis by training women with breast cancer - related weakness using high effort plus moderate intensity exercise vs low effort combined with moderate intensity muscle exercise,» said Dr. Yue.

This can be especially useful for young women with dense breasts, says Janet Wolter, MD, a medical oncologist and the Brian Piccolo chair of Breast Cancer Research at Rush University Medical Center in Chicago, because their home breast self - exams (BSEs) are trickier to inteBreast Cancer Research at Rush University Medical Center in Chicago, because their home breast self - exams (BSEs) are trickier to intebreast self - exams (BSEs) are trickier to interpret.

«Black women have been noted to present [at a doctor's office] with later stage cancer, which has a worse outcome — and they don't always get adequate care,» says Ruth ORegan, MD, associate professor of hematology and oncology and director of the translational breast cancer research program at Emory University's Winship Cancer Institute in Atcancer, which has a worse outcome — and they don't always get adequate care,» says Ruth ORegan, MD, associate professor of hematology and oncology and director of the translational breast cancer research program at Emory University's Winship Cancer Institute in Atcancer research program at Emory University's Winship Cancer Institute in AtCancer Institute in Atlanta.

«Eating lots of fruits and vegetables, limiting fat intake, and being physically active — as much as they are able — is equally important for women with metastatic breast cancer as it is for women without the disease,» he says.

â $ For a small subgroup of women with strong family histories of breast cancer, we recommend starting screening, including annual mammograms and MRIs, at age 25, â $ says Julie R. Gralow, MD, the director of breast medical oncology at the University of Washington and Fred Hutchinson Cancer Research Center in Secancer, we recommend starting screening, including annual mammograms and MRIs, at age 25, â $ says Julie R. Gralow, MD, the director of breast medical oncology at the University of Washington and Fred Hutchinson Cancer Research Center in SeCancer Research Center in Seattle.

Other breast cancer tests — diagnostic mammograms, ultrasounds, MRIs, and biopsies — are for women with symptoms who, for example, «feel a lump, have redness on the skin of their breast, or have discharge from the nipple,» says Dr. Jokich.

«While there are no guarantees when it comes to developing cancer, what we do know is that women can take steps every day to reduce the odds of developing breast cancer, along with many other cancers and chronic disease,» said Alice Bender, head of nutrition programs at AICR.

«More research should be done, but there is a growing body of evidence which suggests that women previously diagnosed with breast cancer should speak with their doctor about possibly limiting their consumption of alcohol,» says the lead researcher on the study, Marilyn L. Kwan, PhD, a staff scientist at Kaiser Permanente in Oakland.

«Even in a woman with a very high risk of breast cancer, we typically don't recommend starting screening before age 30,» Dr. Andrews says.

«Women who've had previous radiation for breast cancer or younger patients who've had Hodgkins lymphoma with chest radiation — that does increase your risk for lung cancer, but that's not common,» says Dr. Lam.

The researchers say that breast - feeding could be the equivalent of taking the drug tamoxifen for 5 years, which is a well - known way to cut breast cancer risk in women with a family history of the disease.

It's natural for women who are diagnosed with breast cancer to feel anxious about cancerous cells cropping up in their other breast — and it can happen, says Todd Tuttle, MD, chief of surgical oncology at the University of Minnesota Medical School.

«This is going to open up a new opportunity for patients, and also for further research,» said Dr. Edith Perez, chairwoman of the breast cancer clinic at the Mayo Clinic in Jacksonville, Fla. «It has some limitations in that it was done only in premenopausal women, but it is consistent with other studies that have been reported with other drugs in that same class.»

But, there are worries that cancer might reappear in a woman's scalp years after treatment, said Lichtenfeld and Dr. Richard Bleicher, breast clinical service line leader with Fox Chase Cancer Center in Philadecancer might reappear in a woman's scalp years after treatment, said Lichtenfeld and Dr. Richard Bleicher, breast clinical service line leader with Fox Chase Cancer Center in PhiladeCancer Center in Philadelphia.

«For adults, the biggest concern with BPA is that it may increase the risk of breast cancer in women and reduce sperm counts in men,» says Dr. Carpenter, who explains that BPA can leach out into the water in the bottle.

The LA article goes on: «Dr. Kent Holtorf, a physician and proponent of bioidentical hormones... The website for Holtorf's clinic says that women using bioidentical hormones «feel great» without suffering any of the side effects of «synthetic hormones,» said to include fatigue, depression and weight gain, along with the increased risk of breast cancer and heart disease.

Chemical «relaxers» used to straighten hair are not associated with an increased risk of developing breast cancer among African - American women, say researchers who followed 48,167 Black Women's Health Study participwomen, say researchers who followed 48,167 Black Women's Health Study participWomen's Health Study participants.

Dr. Lee said many times that women with hormone receptor positive breast cancers could especially benefit from natural progesterone supplements because their tumors had progesterone receptors to which the progesterone could bind.

In the past, for example, women with breast cancer were all treated more or less the same, with little regard to the particulars of their cancer, he says.

She \ had to, she said \ - i wish i could thank CATSA for putting and remind women of their woes with breast cancer - well DONE.